Vaccines and Biologics
for better global health
Vaccines and Biologics
for better global health
Vaccines and Biologics for better global health
Meningitec
 
Meningitec
Our commercial product, Meningitec, a vaccine for the prevention of bacterial meningitis and/or septicemia in infants and older age groups, is commercially available within European, Latin American, and Asia Pacific markets.
RELONSIV™
 

RELONSIV

NU100 (RELONSIV) is a proprietary recombinant human interferon beta-1b being developed as a new molecular entity for the treatment of multiple sclerosis (MS).


Partnership Opportunities
 

Partnering

Learn more about existing partnership opportunities with Nuron Biotech.